Prostaglandin E 2 receptor expression in the rat trigeminal-vascular system and other brain structures involved in pain

Neuroscience Letters

Volumn 506, Issue 1, 2012, Pages 64-69

  Myren, Maja ^a   Olesen, Jes ^a   Gupta, Saurabh ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

EP 1; EP 2; EP 3; EP 4; Migraine; Pain; Trigeminal vascular system

Indexed keywords

MESSENGER RNA; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ARTERY; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; DURA MATER; HIPPOCAMPUS; HYPOPHYSIS; HYPOTHALAMUS; MALE; MIGRAINE; NOCICEPTION; NONHUMAN; ORGAN SYSTEMS; PERIAQUEDUCTAL GRAY MATTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SPINAL GANGLION; THALAMUS; TISSUE HOMOGENATE; TRIGEMINAL NUCLEUS; TRIGEMINAL VASCULAR SYSTEM; TRIGEMINUS GANGLION; ANIMAL; BRAIN; CARDIOVASCULAR SYSTEM; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PAIN; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; CARDIOVASCULAR SYSTEM; CEREBRAL ARTERIES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; MALE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER; TRIGEMINAL GANGLION; TRIGEMINAL NUCLEI;

EID: 84855190763     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.10.050     Document Type: Article

References (30)

1. Afridi S.K., Giffin N.J., Kaube H., Friston K.J., Ward N.S., Frackowiak R.S., Goadsby P.J. A positron emission tomographic study in spontaneous migraine. Arch. Neurol. 2005, 62:1270-1275.
2. 2 prostanoid receptor subtypes. Eur. J. Pharmacol. 1997, 340:227-241.
3. Brennan K.C., Charles A. An update on the blood vessel in migraine. Curr. Opin. Neurol. 2010, 23:266-274.
4. Burstein R., Jakubowski M. Neural substrate of depression during migraine. Neurol. Sci. 2009, 30(1 Suppl.):S27-S31.
5. 1 in the rat brain: accumulation in Purkinje cells of the cerebellum. J. Mol. Neurosci. 2005, 27:303-310.
6. Chakravarty A., Sen A. Migraine, neuropathic pain and nociceptive pain: towards a unifying concept. Med. Hypotheses 2010, 74:225-231.
7. Coleman R.A., Smith W.L., Narumiya S. International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 1994, 46:205-229.
8. Dasilva A.F., Granziera C., Tuch D.S., Snyder J., Vincent M., Hadjikhani N. Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraine. Neuroreport 2007, 18:301-305.
9. Di Stefano V., Zaccagnini G., Capogrossi M.C., Martelli F. microRNAs as peripheral blood biomarkers of cardiovascular disease. Vasc. Pharmacol. 2011, 10.1016/j.vph.2011.08.001.
10. Diener H.C. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. Cephalalgia 1999, 19:581-588.
11. 3 prostaglandin E(2) receptor subtype in the rat brain: relationship to sites of interleukin-1-induced cellular responsiveness. J. Comp. Neurol. 2000, 428:5-20.
12. Haack M., Lee E., Cohen D.A., Mullington J.M. Activation of the prostaglandin system in response to sleep loss in healthy humans: potential mediator of increased spontaneous pain. Pain 2009, 145:136-141.
13. Harno H., Hirvonen T., Kaunisto M.A., Aalto H., Levo H., Isotalo E., Kallela M., Kaprio J., Palotie A., Wessman M., Farkkila M. Subclinical vestibulocerebellar dysfunction in migraine with and without aura. Neurology 2003, 61:1748-1752.
14. Jenkins D.W., Feniuk W., Humphrey P.P. Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones. Br. J. Pharmacol. 2001, 134:1296-1302.
15. Knight Y.E., Goadsby P.J. The periaqueductal grey matter modulates trigeminovascular input: a role in migraine?. Neuroscience 2001, 106:793-800.
16. Lafreniere R.G., Cader M.Z., Poulin J.F., Andres-Enguix I., Simoneau M., Gupta N., Boisvert K., Lafreniere F., McLaughlan S., Dube M.P., Marcinkiewicz M.M., Ramagopalan S., Ansorge O., Brais B., Sequeiros J., Pereira-Monteiro J.M., Griffiths L.R., Tucker S.J., Ebers G., Rouleau G.A. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat. Med. 2010, 16:1157-1160.
17. Moulton E.A., Schmahmann J.D., Becerra L., Borsook D. The cerebellum and pain: passive integrator or active participator?. Brain Res. Rev. 2010, 65:14-27.
18. 2 dilatory receptors in the rat craniovascular system in relevance to migraine. Cephalalgia 2010, 30:1110-1122.
19. Negishi M., Sugimoto Y., Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim. Biophys. Acta 1995, 1259:109-119.
20. 2 subtype. Prostaglandins 1997, 54:713-725.
21. 3 receptors. Brain Res. 1994, 663:287-292.
22. Pomeranz B., Cheng R., Law P. Acupuncture reduces electrophysiological and behavioral responses to noxious stimuli: pituitary is implicated. Exp. Neurol. 1977, 54:172-178.
23. Popp L., Haussler A., Olliges A., Nusing R., Narumiya S., Geisslinger G., Tegeder I. Comparison of nociceptive behavior in prostaglandin E, F, D, prostacyclin and thromboxane receptor knockout mice. Eur. J. Pain 2009, 13:691-703.
24. Sarchielli P., Alberti A., Codini M., Floridi A., Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 2000, 20:907-918.
25. Tang J.S, Qu C.L., Huo F.Q. The thalamic nucleus submedius and ventrolateral orbital cortex are involved in nociceptive modulation: a novel pain modulation pathway. Prog. Neurobiol. 2009, 89:383-389.
26. Weiller C., May A., Limmroth V., Juptner M., Kaube H., Schayck R.V., Coenen H.H., Diener H.C. Brain stem activation in spontaneous human migraine attacks. Nat. Med. 1995, 1:658-660.
27. 2) induces headache in healthy subjects. Cephalalgia 2009, 29:509-519.
28. 2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells. Eur. J. Pharmacol. 2006, 535:69-77.
29. Zagami A.S., Lambert G.A. Craniovascular application of capsaicin activates nociceptive thalamic neurones in the cat. Neurosci. Lett. 1991, 121:187-190.
30. 2 receptors in the rat brain and neuronal responses to systemic inflammation. Eur. J. Neurosci. 1999, 11:2651-2668.